Aspira Pathlab & Diagnostics Limited (BOM:540788)

India · Delayed Price · Currency is INR

99.85

-5.25 (-5.00%)

At close: Jul 10, 2026

90.34% (1Y)

Market Cap	1.03B +72.2%
Revenue (ttm)	249.82M +13.6%
Net Income	513.00K -97.5%
EPS	0.05 -97.5%
Shares Out	10.29M
PE Ratio	2,003.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,906
Open	107.25
Previous Close	105.10
Day's Range	99.85 - 107.25
52-Week Range	49.00 - 135.88
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About BOM:540788

Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was ... [Read more]

Industry Medical Laboratories

Founded 1973

Employees 141

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540788

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:540788's revenue was 249.82 million, an increase of 13.56% compared to the previous year's 219.99 million. Earnings were 513,000, a decrease of -97.46%.

Financial Statements